Artificial cells for the development of cell therapy

Cell Transplantation

Volumn 17, Issue 1-2, 2008, Pages 3-9

  Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cell therapies; Cre loxP site specific recombination; Hayflick's limit; Immortality; M1 phase; M2 phase; Reversible immortalization; Senescence

Indexed keywords

CRE RECOMBINASE; RETROVIRUS VECTOR;

ANIMAL CELL; CELL CULTURE; CELL CYCLE M PHASE; CELL IMMORTALIZATION; CELL THERAPY; CONFERENCE PAPER; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; LOXP SITE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SENESCENCE; SPECIES DIFFERENCE; SWINE; TISSUE CULTURE; TISSUE ENGINEERING;

PORCINE ENDOGENOUS RETROVIRUS; SUS;

EID: 42249086481     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000008783907099     Document Type: Conference Paper

References (19)

1. Bodnar, A. G.; Ouellette, M.; Frolkis, M.; Holt, S. E.; Chiu, C. P.; Morin, G. B.; Harley, C. B.; Shay, J. W.; Lichtsteiner, S.; Wright, W. E. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352; 1998.
2. Forest, C.; Czerucka, D.; Negrel, R.; Ailhaud, G. Establishment of a human cell line after transformation by a plasmid containing the early region of the SV40 genome. Cell Biol. Int. Rep. 7:73-81; 1983.
3. Halvorsen, T. L.; Leibowitz, G.; Levine, F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol. Cell. Biol. 19:1864-1870; 1999.
4. Jenkins, J. R.; Rudge, K.; Currie, G. A. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature 312:651-654; 1984.
5. Kobayashi, N.; Fujiwara, T.; Westerman, K. A.; Inoue, Y.; Sakaguchi, M.; Noguchi, H.; Miyazaki, M.; Cai, J.; Tanaka, N.; Fox, I. J.; Leboulch, P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287:1258-1262; 2000.
6. Lane, D. P. Cell immortalization and transformation by the p53 gene. Nature 312:596-597; 1984.
7. Maruyama, M.; Kobayashi, N.; Westerman, K. A.; Sakaguchi, M.; Allain, J. E.; Totsugawa, T.; Okitsu, T.; Fukazawa, T.; Weber, A.; Stolz, D. B.; Leboulch, P.; Tanaka, N. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation 77:446-451; 2004.
8. Matsumura, T.; Takesue, M.; Westerman, K. A.; Okitsu, T.; Sakaguchi, M.; Fukazawa, T.; Totsugawa, T.; Noguchi, H.; Yamamoto, S.; Stolz, D. B.; Tanaka, N.; Leboulch, P.; Kobayashi, N. Establishment of an immortalized human liver endothelial cell line with SV40T and hTERT. Transplantation 77:1357-1365; 2004.
9. Mayne, L. V.; Priestley, A.; James, M. R.; Burke, J. F. Efficient immortalization and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp. Cell Res. 162:530-538; 1986.
10. Nagahara, H.; Vocero-Akbani, A. M.; Snyder, E. L.; Ho, A.; Latham, D. G.; Lissy, N. A.; Becker-Hapak, M.; Ezhevsky, S. A.; Dowdy, S. F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induced cell migration. Nat. Med. 4:1449-1452; 1998.
11. Narushima, M.; Kobayashi, N.; Okitsu, T.; Tanaka, Y.; Li, S. A.; Chen, Y.; Miki, A.; Tanaka, K.; Nakaji, S.; Takei, K.; Soto-Gutierrez, S.; Rivas-Carrillo, J. D.; Navarro-Alvarez, N.; Jun, H. S.; Westerman, K. A.; Noguchi, H.; Lakey, J. R.; Leboulch, P.; Tanaka, N.; Yoon, J. W. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat. Biotechnol. 23:1274-1282; 2005.
12. Noguchi, H.; Kobayashi, N.; Westerman, K. A.; Sakaguchi, M.; Okitsu, T.; Totsugawa, T.; Watanabe, T.; Matsumura, T.; Fujiwara, T.; Ueda, T.; Miyazaki, M.; Tanaka, N.; Leboulch, P. Controlled expansion of human endothelial cell populations by Cre/loxP-based reversible immortalization. Hum. Gene Ther. 13:321-334; 2002.
13. Okitsu, T.; Kobayashi, N.; Jun, H. S.; Shin, S.; Kim, S. J.; Han, J.; Kwon, H.; Sakaguchi, M.; Totsugawa, T.; Kohara, M.; Westerman, K. A.; Tanaka, N.; Leboulch, P.; Yoon, J. W. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 53:105-112; 2004.
14. Shay, J. W.; Wright, W. E. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40T large T-antigen. Exp. Cell Res. 184:109-118; 1989.
15. Sternberg, N.; Hamilton, D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol. 150:467-486; 1981.
16. Totsugawa, T.; Yong, C.; Rivas-Carrillo, J. D.; Soto-Gutierrez, A.; Navarro-Alvarez, N.; Noguchi, H.; Okitsu, T.; Westerman, K. A.; Kohara, M.; Reth, M.; Tanaka, N.; Leboulch, P.; Kobayashi, N. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J. Hepatol. 47:74-82; 2007.
17. Watanabe, T.; Shibata, N.; Westerman, K. A.; Okitsu, T.; Allain, J. E.; Sakaguchi, M.; Totsugawa, T.; Maruyama, M.; Matsumura, T.; Noguchi, H.; Yamamoto, S.; Hikida, M.; Ohmori, A.; Reth, M.; Weber, A.; Tanaka, N.; Leboulch, P.; Kobayashi, N. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation 75:1873-1880; 2003.
18. Westerman, K. A.; Leboulch, P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc. Natl. Acad. Sci. USA 93:8971-8976; 1996.
19. Zhu, J.; Wang, H.; Bishop, J. M.; Blackburn, E. H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96:3723-3728; 1999.